免疫疗法
嵌合抗原受体
细胞疗法
放射治疗
免疫学
医学
免疫系统
癌症免疫疗法
汽车T细胞治疗
T细胞
细胞
生物
内科学
遗传学
作者
Beilei Wang,Changsheng Li,Yixian Yang
出处
期刊:Int J Immunol
日期:2020-01-05
卷期号:43 (1): 93-97
标识
DOI:10.3760/cma.j.issn.1673-4394.2020.01.018
摘要
Cellular immunotherapy is recognized as the fourth tumor treatment after surgery, radiotherapy and chemotherapy.Chimeric antigen receptor (CAR)-T-cell therapy belongs to adoptive cellular immunotherapy.CAR-T not only has made great breakthroughs in cancer treatment, but also has good application prospects in the treatment of infectious diseases and autoimmune diseases.This article reviews the development history, clinical applications, current problems and the latest research progress of CAR-T cell immunotherapy.
Key words:
Chimeric antigen receptor; T cell; Immunotherapy; Tumor
科研通智能强力驱动
Strongly Powered by AbleSci AI